Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair
- PMID: 32987830
- PMCID: PMC7583030
- DOI: 10.3390/ijms21197038
Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair
Abstract
The use of mesenchymal stem cells (MSC) for the treatment of cutaneous wounds is currently of enormous interest. However, the broad translation of cell therapies into clinical use is hampered by their efficacy, safety, manufacturing and cost. MSCs release a broad repertoire of trophic factors and immunomodulatory cytokines, referred to as the MSC secretome, that has considerable potential for the treatment of cutaneous wounds as a cell-free therapy. In this review, we outline the current status of MSCs as a treatment for cutaneous wounds and introduce the potential of the MSC secretome as a cell-free alternative for wound repair. We discuss the challenges and provide insights and perspectives for the future development of the MSC secretome as well as identify its potential clinical translation into a therapeutic treatment.
Keywords: mesenchymal stem cells; secretome; wound healing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ahangar P., Woodward M., Cowin A.J. Advanced wound therapies. Wound Pract. Res. 2018;26:58–68.
-
- Johnson R.M., Richard R. Partial-thickness burns: Identification and management. Adv. Skin Wound Care. 2003;16:178–187. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
